CA Patent

CA2662571A1 — Pharmaceutical compositions comprising nilotinib

Assigned to Novartis AG · Expires 2008-04-03 · 18y expired

What this patent protects

A pharmaceutical composition, especially capsules, comprising granules co ntaining nilotinib or a salt thereof with at least one pharmaceutically acce ptable excipient. The granules may be produced by a wet granulation process.

USPTO Abstract

A pharmaceutical composition, especially capsules, comprising granules co ntaining nilotinib or a salt thereof with at least one pharmaceutically acce ptable excipient. The granules may be produced by a wet granulation process.

Drugs covered by this patent

Patent Metadata

Patent number
CA2662571A1
Jurisdiction
CA
Classification
—
Expires
2008-04-03
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.